Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

UnitedHealth Group Inc. diskutieren

UnitedHealth Group Inc.

WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Aktie / Anbieter & Dienstleistungen / Large Cap /

462,95 €
0,54 %

UnitedHealth Group Incorporated (NYSE: UNH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,49 %
Kursziel 544,61
Veränderung
Endet am 23.10.24

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Morgan Stanley from $587.00 to $579.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,20 %
Kursziel 540,17
Veränderung
Endet am 21.11.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,40 %
Kursziel 535,86
Veränderung
Endet am 30.11.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $585.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,91 %
Kursziel 546,23
Veränderung
Endet am 30.11.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $596.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,37 %
Kursziel 559,92
Veränderung
Endet am 30.11.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $610.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,62 %
Kursziel 538,32
Veränderung
Endet am 13.12.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $585.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Sell
Rendite (%) -3,99 %
Kursziel 439,34
Veränderung
Endet am 18.12.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "reduce" rating re-affirmed by analysts at HSBC Holdings plc. They now have a $480.00 price target on the stock, down previously from $550.00.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,19 %
Kursziel 547,55
Veränderung
Endet am 16.01.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $596.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,19 %
Kursziel 555,57
Veränderung
Endet am 16.01.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Stephens from $615.00 to $605.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,68 %
Kursziel 535,33
Veränderung
Endet am 17.01.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Piper Sandler from $584.00 to $581.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,49 %
Kursziel 561,38
Veränderung
Endet am 17.01.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $610.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,24 %
Kursziel 542,36
Veränderung
Endet am 19.01.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,60 %
Kursziel 561,20
Veränderung
Endet am 08.02.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $605.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,79 %
Kursziel 551,42
Veränderung
Endet am 28.02.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $596.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 9,17 %
Kursziel 543,72
Veränderung
Endet am 04.04.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,28 %
Kursziel 540,08
Veränderung
Endet am 05.04.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Morgan Stanley from $618.00 to $584.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 9,65 %
Kursziel 484,42
Veränderung
Endet am 08.04.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Wells Fargo & Company from $600.00 to $525.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 9,74 %
Kursziel 549,87
Veränderung
Endet am 10.04.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 9,99 %
Kursziel 508,65
Veränderung
Endet am 10.04.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at TD Cowen from $607.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat